KRN125

KRN125 · Kyowa Kirin Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KRN125, covering 2021-01-22 to 2023-02-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of KRN125 in Patients With Multiple Myeloma and Malignant Lymphoma [Phase 2]